Jazz Pharmaceutical stocks will be sold in the first quarter of 2019, a day after the company announced that it had reached a deal to acquire the private equity firm Cerberus Capital Management.In a statement, Cerberus said it was selling 10.3 million shares of Jazz to Cerberus, a $20 million cash payment and an option […]

Continue Reading...